AAAAAA
Results:
1-24
|
Results: 24
Authors:
Ball, MP
Coons, VB
Buchanan, RW
Citation: Mp. Ball et al., A program for treating olanzapine-related weight gain, PSYCH SERV, 52(7), 2001, pp. 967-969
Authors:
Tek, C
Kirkpatrick, B
Buchanan, RW
Citation: C. Tek et al., A five-year followup study of deficit and nondeficit schizophrenia, SCHIZOPHR R, 49(3), 2001, pp. 253-260
Authors:
Bellack, AS
Buchanan, RW
Gold, JM
Citation: As. Bellack et al., The American Psychiatric Association practice guidelines for schizophrenia: Scientific base and relevance for behavior therapy, BEHAV THER, 32(2), 2001, pp. 283-308
Authors:
Kirkpatrick, B
Buchanan, RW
Ross, DE
Carpenter, WT
Citation: B. Kirkpatrick et al., A separate disease within the syndrome of schizophrenia, ARCH G PSYC, 58(2), 2001, pp. 165-171
Authors:
Weiner, E
Ball, MP
Summerfelt, A
Gold, J
Buchanan, RW
Citation: E. Weiner et al., Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia, AM J PSYCHI, 158(4), 2001, pp. 635-637
Authors:
Breier, A
Buchanan, RW
Irish, D
Carpenter, WT
Citation: A. Breier et al., Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns, PSYCH SERV, 51(10), 2000, pp. 1249-1253
Authors:
Blyler, CR
Gold, JM
Iannone, VN
Buchanan, RW
Citation: Cr. Blyler et al., Short form of the 'WAIS-III for use with patients with schizophrenia, SCHIZOPHR R, 46(2-3), 2000, pp. 209-215
Authors:
Carpenter, WT
Breier, A
Buchanan, RW
Kirkpatrick, B
Shepard, P
Weiner, E
Citation: Wt. Carpenter et al., Mazindol treatment of negative symptoms, NEUROPSYCH, 23(4), 2000, pp. 365-374
Authors:
Kirkpatrick, B
Kopelowicz, A
Buchanan, RW
Carpenter, WT
Citation: B. Kirkpatrick et al., Assessing the efficacy of treatments for the deficit syndrome of schizophrenia, NEUROPSYCH, 22(3), 2000, pp. 303-310
Authors:
Buckley, PF
Buchanan, RW
Tamminga, CA
Schulz, SC
Citation: Pf. Buckley et al., Schizophrenia research: A progress report, summarizing proceedings of the 1999 International Congress on Schizophrenia Research, SCHIZO BULL, 26(2), 2000, pp. 411-419
Authors:
Arango, C
Kirkpatrick, B
Buchanan, RW
Citation: C. Arango et al., Fluoxetine as an adjunct to conventional antipsychotic treatment of schizophrenia patients with residual symptoms, J NERV MENT, 188(1), 2000, pp. 50-53
Authors:
Gold, JM
Bish, JA
Iannone, VN
Hobart, MP
Queern, CA
Buchanan, RW
Citation: Jm. Gold et al., Effects of contextual processing on visual conditional associative learning in schizophrenia, BIOL PSYCHI, 48(5), 2000, pp. 406-414
Authors:
Arango, C
Kirkpatrick, B
Buchanan, RW
Citation: C. Arango et al., Neurological signs and the heterogeneity of schizophrenia, AM J PSYCHI, 157(4), 2000, pp. 560-565
Authors:
Bellack, AS
Gold, JM
Buchanan, RW
Citation: As. Bellack et al., Cognitive rehabilitation for schizophrenia: Problems, prospects, and strategies, SCHIZO BULL, 25(2), 1999, pp. 257-274
Authors:
Thaker, GK
Ross, DE
Buchanan, RW
Adami, HM
Medoff, DR
Citation: Gk. Thaker et al., Smooth pursuit eye movements to extra-retinal motion signals: deficits in patients with schizophrenia, PSYCHIAT R, 88(3), 1999, pp. 209-219
Authors:
Carpenter, WT
Kirkpatrick, B
Buchanan, RW
Citation: Wt. Carpenter et al., Schizophrenia: syndromes and diseases, J PSYCH RES, 33(6), 1999, pp. 473-475
Authors:
Carpenter, WT
Arango, C
Buchanan, RW
Kirkpatrick, B
Citation: Wt. Carpenter et al., Deficit psychopathology and a paradigm shift in schizophrenia research, BIOL PSYCHI, 46(3), 1999, pp. 352-360
Authors:
Arango, C
Bartko, JJ
Gold, JM
Buchanan, RW
Citation: C. Arango et al., Prediction of neuropsychological performance by neurological signs in schizophrenia, AM J PSYCHI, 156(9), 1999, pp. 1349-1357
Authors:
Bryant, NL
Buchanan, RW
Vladar, K
Breier, A
Rothman, M
Citation: Nl. Bryant et al., Gender differences in temporal lobe structures of patients with schizophrenia: A volumetric MRI study, AM J PSYCHI, 156(4), 1999, pp. 603-609
Authors:
Amador, XF
Kirkpatrick, B
Buchanan, RW
Carpenter, WT
Marcinko, L
Yale, SA
Citation: Xf. Amador et al., Stability of the diagnosis of deficit syndrome in schizophrenia, AM J PSYCHI, 156(4), 1999, pp. 637-639
Authors:
Carpenter, WT
Buchanan, RW
Kirkpatrick, B
Lann, HD
Breier, AF
Summerfelt, AT
Citation: Wt. Carpenter et al., Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks, AM J PSYCHI, 156(3), 1999, pp. 412-418
Authors:
Carpenter, WT
Buchanan, RW
Kirkpatrick, B
Breier, AF
Citation: Wt. Carpenter et al., Diazepam treatment of early signs of exacerbation in schizophrenia, AM J PSYCHI, 156(2), 1999, pp. 299-303
Authors:
Gold, JM
Queern, C
Iannone, VN
Buchanan, RW
Citation: Jm. Gold et al., Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, I: Sensitivity, reliability, and validity, AM J PSYCHI, 156(12), 1999, pp. 1944-1950
Authors:
Carpenter, WT
Conley, RR
Buchanan, RW
Citation: Wt. Carpenter et al., Schizophrenia, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, 1998, pp. 27-51
Risultati:
1-24
|